Real World Outcomes of Adding Rapid-Acting Insulin Versus Switching to Analog Premix Insulin Among US Patients With Type 2 Diabetes Treated With Insulin Glargine

Patient Preference and Adherence - New Zealand
doi 10.2147/ppa.s49287
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited